highperformr logo

Deciphera Pharmaceuticals's Overview

Total employees432
HeadquartersWaltham
Founded2003

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. They leverage their proprietary Kinase Switch Control Inhibitor platform to develop a diverse portfolio of innovative medicines. Their lead approved product, QINLOCK® (ripretinib), is a switch-control kinase inhibitor for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

Where is Deciphera Pharmaceuticals's Headquarters?

HQ Function

Serves as the corporate headquarters, housing executive leadership, research and development laboratories, clinical operations, and administrative functions.

Notable Features:

Modern office and laboratory facilities situated in a prominent biotech hub, designed to foster innovation and collaboration.

Work Culture:

Characterized by a science-driven, patient-focused, and collaborative environment. Employees are typically mission-oriented, dedicated to advancing oncology treatments.

HQ Significance:

Strategically located in the Greater Boston area, a leading global center for biotechnology, providing access to talent, research institutions, and industry partners.

Values Reflected in HQ: The headquarters likely reflects Deciphera's commitment to innovation, scientific rigor, and collaboration in its design and functionality.

Location:

Deciphera Pharmaceuticals supports its global operations through its U.S. headquarters in Waltham, MA, and its European headquarters in Zug, Switzerland. These key locations facilitate worldwide clinical trial management, drug discovery, regulatory affairs, and commercialization efforts for its oncology therapeutics, particularly focusing on North American and European markets.

Street Address:

200 Smith Street

City:

Waltham

State/Province:

Massachusetts

Country:

United States

Deciphera Pharmaceuticals's Global Presence

Zug, Switzerland

Address: Gubelstrasse 11, 6300 Zug, Switzerland

To manage and expand the commercialization of QINLOCK® and future pipeline products within the European market, and to oversee regional clinical trial activities.

Buying Intent Signals for Deciphera Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Deciphera Pharmaceuticals

As of April 2025, Deciphera Pharmaceuticals' leadership includes:

Steven L. Hoerter - President and Chief Executive Officer
Tucker Kelly - Chief Financial Officer and Treasurer
Matthew L. Sherman, M.D. - Chief Medical Officer
Daniel C. Martin - Chief Commercial Officer
Margarida M. Barroso, Ph.D. - Chief Business Officer
Kelley A. seksual - Chief Human Resources Officer
Thomas P. Kelly - Chief Legal Officer and Secretary

Investors of Deciphera Pharmaceuticals

Deciphera Pharmaceuticals has been backed by several prominent investors over the years, including:

Brightstar Associates LLC
BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Adage Capital Management, L.P.
Redmile Group, LLC
FMR LLC (Fidelity)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

In the past year, Deciphera Pharmaceuticals has seen limited publicly announced changes at the top executive level. Key appointments in the preceding period, such as the Chief Business Officer in mid-2023, continue to shape the company's strategic direction.

Technology (Tech Stack) used by Deciphera Pharmaceuticals

Discover the tools Deciphera Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Deciphera Pharmaceuticals Email Formats and Examples

Deciphera Pharmaceuticals most commonly uses the email format [first_initial][last]@deciphera.com. Other variations might exist but this is the primary structure observed.

flast@deciphera.com

Format

jdoe@deciphera.com

Example

85%

Success rate

News and media

Deciphera PharmaceuticalsMay 7, 2024

Deciphera Pharmaceuticals Reports First Quarter 2024 Financial Results

Deciphera announced its financial results for Q1 2024, highlighting QINLOCK net product revenue of $45.8 million and progress in its clinical pipeline, including the ongoing NDA review for vimseltinib....more

Deciphera PharmaceuticalsApril 1, 2024

Deciphera Pharmaceuticals Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Vimseltinib

The FDA accepted Deciphera's NDA for vimseltinib for the treatment of patients with tenosynovial giant cell tumor (TGCT) and granted Priority Review, with a PDUFA target action date of August 28, 2024....more

Deciphera PharmaceuticalsFebruary 15, 2024

Deciphera Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Deciphera reported its financial results for Q4 and full-year 2023, emphasizing strong QINLOCK sales and pipeline advancements, including the submission of the NDA for vimseltinib....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Deciphera Pharmaceuticals, are just a search away.